REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksR&Q Insurance Regulatory News (RQIH)

Share Price Information for R&Q Insurance (RQIH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.075
Bid: 1.75
Ask: 1.85
Change: 0.00 (0.00%)
Spread: 0.10 (5.714%)
Open: 2.075
High: 0.00
Low: 0.00
Prev. Close: 2.075
RQIH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on discussions with the BMA

22 Dec 2023 07:00

RNS Number : 7001X
R&Q Insurance Holdings Ltd
22 December 2023
 

 

 

 

R&Q Insurance Holdings Limited

 

Update on discussions with the BMA

 

22 December 2023

 

R&Q Insurance Holdings Ltd (AIM-RQIH) ("R&Q" "the Group") today provides an update on discussions with The Bermuda Monetary Authority ("BMA"), the Group's principal insurance regulator.

 

R&Q has, over recent months, engaged closely with the BMA regarding the future strategy for R&Q Legacy, given the proposed sale of Accredited ("the Sale"). As part of these discussions the BMA has requested an independent actuarial review of the required reserves of the remaining Group post the Sale, its capital and its cash flow projections. 

 

The BMA has now notified R&Q that it will need to:

· Pause the redemption of the Tier 2 US$20 million floating rate subordinated notes issued by R&Q Re (Bermuda) Limited which are treated as Tier 2 capital for solvency (the "Bermuda Subordinated Notes") due on 22 December 2023. Accordingly, the Bermuda Subordinated Notes remain outstanding on their terms and R&Q Re (Bermuda) will continue to pay interest on such notes as it accrues.

· Put on hold the approval of any new external legacy transactions to R&Q Re (Bermuda) while the BMA undertakes its review of R&Q Legacy. This includes the UK Motor loss portfolio transfer announced 26 October 2023.

 

Although these decisions by the BMA and the BMA's review will impact R&Q Legacy's ability to complete certain transactions in the short term, the Board remains firmly committed to the legacy plan outlined in the circular published on 14 December 2023. The Board reiterates its belief that a successful Sale represents the best outcome for all stakeholders, including enabling R&Q to undertake a material financial de-leveraging to support the strategy of transitioning the Legacy business to a capital efficient and stable recurring fee-based business model.

 

Ends

 

This announcement contains inside information as stipulated under the UK market abuse regulation no 596/2014, which is part of English law by virtue of the European (withdrawal) act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain.

 

Enquiries to:

R&Q Insurance Holdings Ltd Tel: +44 (0)20 7780 5850

Jeff Hayman

William Spiegel

Tom Solomon

 

Fenchurch Advisory Partners LLP (Financial Adviser) Tel: +44 (0)20 7382 2222

Kunal Gandhi

Brendan Perkins

John Sipp

Richard Locke

Tihomir Kerkenezov

 

Barclays Bank PLC (Financial Adviser and Joint Broker) Tel: +44 (0)20 7632 2322

Gary Antenberg

Richard Bassingthwaighte

Anusuya Nayar Gupta

Grant Bickwit

 

Howden Tiger (Financial Adviser) Tel : +44 (0)20 7398 4888

Rob Bredahl

Leo Beckham

 

Deutsche Numis (Nominated Adviser and Joint Broker) Tel : +44 (0)20 7260 1000

Charles Farquhar

Giles Rolls

 

FTI Consulting Tel: +44 (0)20 3727 1051

Tom Blackwell

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFEWSSEEDSESE
Date   Source Headline
24th Apr 20245:40 pmRNSUpdate on proposed sale of Accredited
19th Apr 20247:00 amRNSAppointment of Non-Executive Directors
12th Apr 20247:00 amRNSUpdate on Trading and Sale of Accredited
12th Mar 20242:33 pmRNSTR-1: Notification of major holdings
1st Mar 20247:00 amRNSComment on recent press speculation
11th Jan 20244:01 pmRNSShareholders approve sale of Accredited
4th Jan 20244:27 pmRNSIncrease in the number of Treasury Shares
2nd Jan 20247:00 amRNSRetirement of Alan Quilter
22nd Dec 20237:00 amRNSUpdate on discussions with the BMA
21st Dec 202311:12 amRNSTR-1: Notification of major holdings
14th Dec 20237:00 amRNSPosting of Circular
16th Nov 20239:58 amRNSTR-1: Notification of major holdings
14th Nov 20237:00 amRNSUpdate on Proposed Sale of Accredited
27th Oct 20234:52 pmRNSPDMR/Director Shareholding and Total Voting Rights
26th Oct 20237:00 amRNSLoss Portfolio Transfer
26th Oct 20237:00 amRNSChange of External Auditor
20th Oct 20235:23 pmRNSProposed Sale of R&Q’s Program Management business
16th Oct 202310:59 amRNSTR-1: Notification of major holdings
29th Sep 20237:00 amRNSResults for the half year ended 30 June 2023
22nd Sep 20237:00 amRNSStatement re Press Comment
20th Sep 202311:55 amRNSTR-1: Notification of major holdings
20th Sep 202311:54 amRNSTR-1: Notification of major holdings
16th Aug 20233:36 pmRNSPDMR/Director Shareholding and Total Voting Rights
28th Jul 20233:18 pmRNSResult of Annual General Meeting
18th Jul 20233:22 pmRNSTR-1: Notification of major holdings
17th Jul 20237:00 amRNSAppointment of Non-Executive Director
30th Jun 202310:08 amRNSAppointment of Non-Executive Director
30th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSResults for the year ended 31 December 2022
26th Jun 20237:00 amRNSAccredited receives independent AM Best Rating
12th Jun 20237:00 amRNSR&Q raises up to $60 million of new equity
6th Jun 20235:31 pmRNSTR-1: Notification of major holdings
5th Jun 202311:23 amRNSTR-1: Notification of major holdings
2nd Jun 20233:50 pmRNSTR-1: Notification of major holdings
16th May 20239:27 amRNSTR-1: Notification of major holdings
10th May 20232:30 pmRNSTR-1: Notification of major holdings
10th May 202311:26 amRNSTR-1: Notification of major holdings
4th Apr 20237:00 amRNSStrategic & Trading Update
31st Mar 20237:00 amRNSAppointment of Non-Executive Chairman
17th Mar 20237:00 amRNSCompletion of Tradesman Sale
3rd Mar 202312:16 pmRNSTR-1: Notification of major holdings
23rd Feb 20237:00 amRNSProgram Management Update and Sale of Tradesman
17th Jan 20237:00 amRNSProgram Management Update
12th Jan 20237:00 amRNSPDMR/Director Shareholding and Total Voting Rights
6th Jan 20237:00 amRNSJoint venture to acquire legacy liabilities
5th Dec 20227:00 amRNSLoss Portfolio Transfer
31st Oct 20227:00 amRNSQ3 2022 Program Management Update
19th Oct 20224:40 pmRNSSecond Price Monitoring Extn
19th Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 20229:24 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.